Open AccessInterstitial Granulomatous Dermatitis as an Adverse Reaction to Vedolizumab
Author(s) -
Beuerlein
Publication year - 2022
Publication title -
cutis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.289
H-Index - 53
eISSN - 2326-6929
pISSN - 0011-4162
DOI - 10.12788/cutis.0467
Subject(s) - medicine , vedolizumab , dermatology , rash , maculopapular rash , erythema , hypersensitivity reaction , complication , adverse effect , ulcerative colitis , pathology , immunology , surgery , disease
A 61-year-old woman with a medical history of ulcerative colitis (UC) developed an erythematous, mildly pruritic, maculopapular rash that was histologically consistent with reactive granulomatous dermatitis (RGD) with interstitial granulomatous dermatitis (IGD)-type features 1 week after vedolizumab infusion. Awareness of this complication is key to enhanced recognition and appropriate management as use of this medication becomes more prevalent.